Trial intelligence / Profile preview

Hormone therapy combined with donepezil in women with mild cognitive impairment

KCT0002516Phase 4Recruiting

Sponsor
Samsung Medical Center
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of donepezil in Mild Cognitive Impairment (MCI), sponsored by Samsung Medical Center. Started Jan 2008; status: recruiting.

02

Drugs

donepezil
03

Conditions

Mild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on KCT0002516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0002516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call